Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Finasteride 1-mg doesn't harm sperm or pregnancy chances.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Smoking increases the risk of hair loss, especially male pattern baldness.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

PRP injections improve hair thickness for baldness.

Finasteride may help treat chronic CSC, improving vision.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Right hand finger ratio may predict male hair loss.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Wearing a cap doesn't affect quality of life for Indian men with hair loss, but severe hair loss does lower it. Older men have more severe hair loss, and those who wear caps more often want less treatment.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.